CancerConsultant.com reported today on new results for the treatment of malignant pleural mesothelioma with the cancer drug Alimta plus a platinum compound such as cisplatin or carboplatin. http://patient.cancerconsultants.com/CancerNews.aspx?DocumentId=40044
According to the article, "the chemotherapy combination consisting of Alimta plus a platinum compound provides signficant anticancer activity in patients with newly diagnsed mesothelioma.
According to Eli Lilly, Alimta in combination with Cisplatin is the only chemotherapy agent to be FDA approved for the treatment of maligant pleural mesothelioma. http://www.lillyoncology.com/professionals/alimta_mpm_clinical_data.jsp
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment